" class="no-js "lang="en-US"> Companies Archive - Page 80 of 145 - Medtech Alert
Tuesday, September 23, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Mithra | Pharmtech Focus

Mithra

View Company

 ViCentra | Pharmtech Focus

ViCentra

View Company

 BostonGene | Pharmtech Focus

BostonGene

View Company

 QuantaMatrix | Pharmtech Focus

QuantaMatrix

View Company

 Sobi | Pharmtech Focus

Sobi

View Company

 Foghorn Therapeutics | Pharmtech Focus

Foghorn Therapeutics

View Company

 Bloom Science | Pharmtech Focus

Bloom Science

View Company

 BlueSky Immunotherapies | Pharmtech Focus

BlueSky Immunotherapies

View Company

 Vésale Bioscience | Pharmtech Focus

Vésale Bioscience

View Company

 Massachusetts Institute of Technology (MIT) | Pharmtech Focus

Massachusetts Institute of Technology (MIT)

Load More Results